Response to "Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies". [electronic resource]
Producer: 20191010Description: 369-370 p. digitalISSN:- 1097-6817
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.